Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excitotoxic injury in cultured hippocampal neurons-Reference-Cited by-同舟云学术

Hepatocyte growth factor improves synaptic localization of the NMDA receptor and intracellular signaling after excitotoxic injury in cultured hippocampal neurons

Published:2008-03 Issue:1 Volume:210 Page:83-94
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Akita Hiromi,Takagi Norio,Ishihara Naoko,Takagi Keiko,Murotomi Kazutoshi,Funakoshi Hiroshi,Matsumoto Kunio,Nakamura Toshikazu,Takeo Satoshi

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference55 articles.

1. Expression of HGF and cMet in the developing and adult brain;Achim;Brain Res. Dev. Brain Res.,1997

2. Transfection of N-methyl-d-aspartate receptors in a nonneuronal cell line leads to cell death;Anegawa;J. Neurochem.,1995

3. Hepatocyte growth factor and the kidney: it is not just for the liver;Balkovetz;Int. Rev. Cytol.,1999

4. Subunit-specific NMDA receptor trafficking to synapses;Barria;Neuron,2002

5. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains;Brenman;Cell,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse neurodevelopment in children associated with prenatal exposure to fine particulate matter (PM2.5) - Possible roles of polycyclic aromatic hydrocarbons (PAHs) and mechanisms involved;Reproductive Toxicology;2024-09

2. Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration;Expert Opinion on Investigational Drugs;2024-05-29

3. The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators;Journal of Alzheimer's Disease;2023-03-07

4. Fosgonimeton, a Novel Positive Modulator of the HGF/MET System, Promotes Neurotrophic and Procognitive Effects in Models of Dementia;Neurotherapeutics;2022-12-20

5. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer’s Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial;Journal of Alzheimer's Disease;2022-04-05